APSR2026-1001

 
Late-Breaking
Submitted
Oral Presentation
AO28-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1243937-46903-APSR-AO28-005-Peiyan Zheng_440965.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Peiyan Zheng * The First Affiliated Hospital of Guangzhou Medical University Department of Clinical Laboratory Guangzhou China
Baoqing Sun - The First Affiliated Hospital of Guangzhou Medical University Department of Clinical Laboratory Guangzhou China
Jian-Lin Wu - Macau University of Science and Technology Faculty of Chinese Medicine, Macau China
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Peiyan
Zheng
gdmcslxx@126.com
+15002039150
41-50
China
Original Research
A circulating odd-chain fatty acid biomarker signature distinguishes pediatric allergic rhinitis with asthma from related allergic airway phenotypes
Maximum 25 words
Abstract Content
Reliable biomarkers for identifying allergic rhinitis with asthma (ARA) and distinguishing it from related allergic airway phenotypes remain lacking in pediatric populations, limiting disease stratification and precision management. We aimed to identify and validate circulating metabolic biomarkers associated with pediatric ARA.
Serum samples from 380 participants, including healthy controls (HC), allergic rhinitis (AR), asthma (AS), and ARA, underwent untargeted carboxylomics profiling using Sensitive Profiling for ChemoSelective Derivatization Carboxylomics (SPCSDCarboxyl). Candidate biomarkers were evaluated in mouse models and validated in an independent cohort (n = 125) using targeted carboxylomics. Multivariate analyses, machine-learning approaches, and receiver operating characteristic (ROC) analyses were applied to assess biomarker performance.
ARA exhibited a distinct metabolic profile characterized by altered circulating odd-chain fatty acids (OCFAs). Valeric acid, heptanoic acid, nonanoic acid, undecanoic acid, and isovaleric acid were consistently identified in both the discovery and validation cohorts. Targeted validation confirmed reproducible elevations of OCFAs in ARA. Heptanoic acid, nonanoic acid, and undecanoic acid demonstrated excellent performance for distinguishing ARA from HC, with area under the curve (AUC) values of 0.96, 0.98, and 0.94, respectively. Least absolute shrinkage and selection operator regression identified valeric acid and undecanoic acid as the principal variables distinguishing ARA from AR. Notably, valeric acid showed the strongest ability to differentiate ARA from isolated AR (AUC = 0.72), while its combination with undecanoic acid modestly improved classification performance (AUC = 0.74). OCFA levels were significantly associated with inflammatory indices and pulmonary function parameters, and similar alterations were observed in allergic airway disease mice.
These findings identify an OCFA-associated metabolic biomarker signature of pediatric ARA and support the existence of a distinct immunometabolic phenotype characterized by perturbations in propionyl-CoA-related metabolism, branched-chain amino acid catabolism, and fatty acid oxidation. Among the identified biomarkers, valeric acid uniquely discriminated ARA from isolated AR, highlighting its potential utility for disease stratification and precision management of pediatric allergic airway disease.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Allergic rhinitis with asthma; immunometabolism; odd-chain fatty acids; metabolomics; pediatric allergic airway diseases; endotype stratification
maximum 3 keywords and no abbreviations, separated by commas
Thanks to the administrators, data managers, statisticians, and other staff of Biobank for Respiratory Diseases in the National Clinical Research Center for Respiratory Disease (BRD-NCRCRD, Guangzhou, Southern China). Furthermore, we would like to thank Sitong Liu and Manyun Jiang for their contribution to data processing and scientific discussions. Lastly, we would like to acknowledge Xueqing Liang (Respiratory Immunology Centre of the First Affiliated Hospital of Guangzhou Medical University) and Yanting Fang (BRD-NCRCRD) for the deterministic linkage of both databases and for reviewing the data request. The authors declare that they have no conflicts of interest.
311